Swing Therapeutics Closes $10.3M Series A Funding Round, Begins Enrollment In Pivotal Phase 3 Clinical Trial
Amount Raised
$10.3 Million
Round Type
Series A
San FranciscoBiotechnologyDescription
Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has closed a $10.3M Series A funding round led by JAZZ Venture Partners with participation by Alumni Ventures, AME Cloud Ventures, Asahi Kasei Corporate Ventures, Gaingels, Kicker Ventures, Mana Ventures, and Metrodora Ventures. The company also announced the commencement of its PROSPER-FM pivotal Phase 3 trial for its digital therapeutic for the treatment of fibromyalgia, which has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation.
Quick answer
Swing Therapeutics raised $10.3 Million in a Series A round, dated June 16, 2022. Swing Therapeutics is based in San Francisco, California, United States.
- How much did Swing Therapeutics raise?
- Swing Therapeutics raised $10.3 Million in a Series A round on June 16, 2022.
- What does Swing Therapeutics do?
- Swing Therapeutics was founded in 2019 with the goal of developing digital treatments and services in disease areas where patients are not well-served, and where digital interventions may be effective.
- Where is Swing Therapeutics based and how big is it?
- Swing Therapeutics is based in San Francisco, California, United States. Fundz records about 22 employees.
- Who are the decision-makers at Swing Therapeutics?
- Fundz holds 2 contacts at Swing Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Swing Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $3M (Seed) on July 29, 2022.
- TendoNova raised $215K (Seed) on July 29, 2022.
- Novasenta Inc. raised $40M (Series A) on July 29, 2022.
- Ascribe Bioscience Inc raised $3.2M (Seed) on July 29, 2022.
- BiOWiSH Technologies raised $5M on July 29, 2022.
- Medcura raised $3.2M on July 29, 2022.
Who to call at Swing Therapeutics, and when
A new round usually means Swing Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Swing Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Swing Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Swing Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Swing Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSwing Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.